Champagne, IL, United States of America

Thomas Uzzell

This inventor holds 1 USPTO granted patent. Top assignee: Magainin Pharmaceuticals, Inc.. Active years: 1998.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas Uzzell: Innovator in Antimicrobial Peptides

Introduction

Thomas Uzzell is a notable inventor based in Champagne, IL (US). He has made significant contributions to the field of antimicrobial research, particularly through his innovative work with peptides derived from hagfish intestine. His research focuses on the development of new antimicrobial agents that can potentially address various health challenges.

Latest Patents

Uzzell holds a patent for a "Family of linear antimicrobial peptides from hagfish intestine." This invention describes a new family of linear antimicrobial peptides isolated from hagfish intestine, which possess unique antimicrobial properties. The antibiotics obtained from this research include peptides with specific chemical sequences that have shown promise in combating bacterial infections.

Career Highlights

Throughout his career, Uzzell has been associated with Magainin Pharmaceuticals, Inc., where he has contributed to the advancement of antimicrobial therapies. His work has been instrumental in exploring the potential of natural peptides as effective antibiotics, paving the way for new treatment options.

Collaborations

Uzzell has collaborated with esteemed colleagues such as Michael A. Zasloff and Ann Shinnar. These partnerships have enhanced the research and development of antimicrobial peptides, fostering innovation in the field.

Conclusion

Thomas Uzzell's contributions to antimicrobial research highlight the importance of natural compounds in developing new therapeutic agents. His work continues to inspire advancements in the fight against infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…